Pfiz­er is mak­ing a $500M state­ment to­day: Here’s how you be­come a lead play­er in the boom­ing gene ther­a­py sec­tor

Three years ago, Pfiz­er an­ted up $150 mil­lion in cash to buy Bam­boo Ther­a­peu­tics in Chapel Hill, NC as it cau­tious­ly stuck a toe in the small gene ther­a­py pool of re­search and de­vel­op­ment.

Com­pa­ny ex­ecs fol­lowed up a year lat­er with a $100 mil­lion ex­pan­sion of the man­u­fac­tur­ing op­er­a­tions they picked up in that deal for the UNC spin­out, which came with $495 mil­lion in mile­stones.

And now they’re re­al­ly go­ing for it.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER